Pathway signatures derived from on-treatment tumor specimens predict response to anti-PD1 blockade in metastatic melanoma.
Du K, Wei S, Wei Z, Frederick DT, Miao B, Moll T, Tian T, Sugarman E, Gabrilovich DI, Sullivan RJ, Liu L, Flaherty KT, Boland GM, Herlyn M, Zhang G.
Du K, et al. Among authors: wei s, wei z.
Nat Commun. 2021 Oct 15;12(1):6023. doi: 10.1038/s41467-021-26299-4.
Nat Commun. 2021.
PMID: 34654806
Free PMC article.